Zanamivir overdosage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Zanamivir}} {{CMG}} ==Overdosage== There have been no reports of overdosage from administration of RELENZA.<ref>{{Cite web | last = | first =|title = http://www.a...")
 
mNo edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Zanamivir}}
{{Zanamivir}}
{{CMG}}
{{CMG}}; {{AE}} {{SS}}


==Overdosage==
==Overdosage==
There have been no reports of overdosage from administration of RELENZA.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf | publisher = |date = | accessdate = }}</ref>
There have been no reports of overdosage from administration of RELENZA.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf | publisher = |date = | accessdate = }}</ref>


==References==
==References==
Line 12: Line 11:
{{FDA}}
{{FDA}}


[[Category:Antiviral]]
[[Category:Antibiotics]]
[[Category:Wikinfect]]
[[Category:Wikinfect]]

Latest revision as of 23:54, 2 January 2014

Zanamivir
RELENZA® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Directions for Use
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Overdosage

There have been no reports of overdosage from administration of RELENZA.[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.